Sermorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates your pituitary gland to produce more natural Growth Hormone. It’s used for anti-aging, recovery, sleep quality and body composition.
Already have an account? Log in
SEQUORA Sermorelin 5mg is a synthetic peptide that mimics part of the body’s growth hormone-releasing hormone (GHRH). It signals the pituitary gland to release growth hormone, which helps regulate growth, tissue maintenance and metabolism. It’s used as a performance peptide to aid with endurance, muscle growth and anti-aging.
The 5mg figure indicates the total stated content across all three compounds, not the concentration or amount delivered per withdrawal. Review the specifications for your selected format.
All of our products are third party laboratory tested to ensure both purity and verification of the peptide itself.
SEQUORA GLOW is a product name for an injectable blend of three peptides: GHK-Cu, BPC-157, and TB-500. The name GLOW is commonly used by most clinics and vendors for the same trio, and each ingredient is a separate compound with its own research history.
KLOW is GLOW plus KPV, which makes it a four-peptide blend. KPV is a short peptide that the FDA lists among substances nominated for compounding, and its regulatory story is covered in the status section below. The other three ingredients are identical in both products.
KPV’s main benefit is inflammation battling properties, so if this isn’t something you’re looking to treat or suffer with, then GLOW will have the same benefits as KLOW at a smaller price point.
GLOW’s characteristic blue colour comes from GHK-Cu, the copper peptide in the blend. GHK is a three-amino-acid peptide that binds to a copper ion. This complex absorbs certain wavelengths of visible light, giving it its blue appearance.
SEQUORA GLOW contains 50mg of GHK-Cu within its 70mg peptide blend, making it approximately 71% of the stated peptide content. BPC-157 and TB-500 do not normally contribute a blue colour.
The freeze-dried powder may appear pale blue, while a dissolved solution can look clear blue. Its appearance varies with concentration, formulation and lighting.
Side effects come from clinical trials and patient studies and are not confirmed medically. Injection site reactions are the most frequent as that’s a normal reaction to GHK-Cu and mild sensitivity or soreness around the injection site.
Product information, handling and safety
What Temperature should I store my Wolverine Stack at?
What are the best practices for using Wolverine Stack safely?
The documentation behind Wolverine Stack and it's uses
Sermorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates your pituitary gland to produce more natural Growth Hormone. It’s used for anti-aging, recovery, sleep quality and body composition.
Upon delivery store in a refridgerator between 2-8°C.
Avoid dropping or heavy-handling of your Sermorelin Blend.
Please do not freeze your SEQUORA Sermorelin Pen as this can compromise the peptide.
Your product has been shipped in secure packaging to prevent any potential issues however if you believe your peptides have been compromised contact us directly.
Your SEQUORA Sermorelin Pen will last 12 months from the date of manufacture providing you follow the storage instructions provided.
SEQUORA Sermorelin Vials before reconstitution can last up to 4 years at -5°C
Sermorelin can be kept at room temperature however it’s shelf life when held at this temperature reduces to 1-2 months.
Before handling your Sermorelin, needles or injection material, ensure your research area is clean and clear.
Wash your hands with warm water and soap and allow to dry fully before handling any SEQUORA products to prevent cross contamination or infection risks.
If at any point the cleanliness of your injection or environment is compromised, restart this step.
Never re-use or share needles/syringes. Ensure your needle tips or syringe is sealed and new before injection.
Before using your SEQUORA Sermorelin Pen, using an alcohol swab, wipe the tip of the cartridge after removing the lid to the pen.
If at any point you touch something unhygienic or potentially dirty, re-wash your hands and use new equipment.
Ensure that your needle tips, syringes and vials are safely disposed of post-use.
This could mean a sharps bin or safe container. Most needle tips and syringes have removable tops that can be replaced onto the used needle.
Try to keep your injection site clean for atleast 30 minutes post-injection to prevent infection risks.
Sermorelin can cause unwanted reactions. Potential injection-site reactions, flushing, headache and dizziness. Personal reports also describe changes in sleep and alertness, but these accounts cannot establish how frequently symptoms occur or whether sermorelin caused them.
Recognised side effects
Sleep and next-day alertness
Some people describing prescribed sermorelin use report disrupted sleep, unusually heavy sleep or prolonged morning grogginess. Others report improved sleep. These contrasting experiences mean that better sleep should not be assumed and significant daytime impairment should be reviewed.
Puffy hands, feet or other swelling
New swelling requires medical assessment. It may reflect fluid retention or another medical problem and should not automatically be attributed to increasing the dose too quickly.
Sudden swelling of the face, lips, tongue or throat is different from gradual puffiness and may indicate a serious allergic reaction.
Allergic reactions
Possible warning signs include widespread itching, hives, a severe rash, facial swelling or difficulty breathing or swallowing. Personal reports describe reactions after both initial exposure and previous uneventful use. Prior tolerance does not guarantee that a future administration will be safe.
When to contact a medical professional
Seek prompt advice for persistent headaches, recurrent dizziness, new hand or foot swelling, troublesome sleep changes or marked daytime sleepiness. These symptoms warrant review of the treatment and other possible causes rather than an automatic dose adjustment.
Symptoms requiring urgent help
Stop administration and call 999 for difficulty breathing, swelling of the tongue or throat, chest pain or collapse. Sudden facial swelling with widespread hives or breathing symptoms also requires emergency help.
Seek urgent medical advice for widespread hives or a severe rash even without breathing symptoms. A sudden severe headache, headache with visual changes or new weakness also requires urgent assessment.
Side-effect management should be guided by a medical professional.
Persistent headache
Seek urgent assessment for a sudden severe headache, visual changes, vomiting or neurological symptoms.
Dizziness or lightheadedness
Puffy hands or feet
Sleep disruption or morning grogginess
Injection-site irritation
Hives, severe rash or suspected allergy
Stop use and seek urgent medical advice. Do not restart at a lower dose, switch batches or take an antihistamine simply to enable another administration. A reaction can develop despite previous uneventful use.
Call 999 for breathing difficulty, tongue or throat swelling, chest pain or collapse. If you have a prescribed adrenaline auto-injector, follow your emergency allergy plan and call 999.
Sermorelin is a peptide best used over a long duration, named a “course”. The calculations below are based on the SEQUORA 5mg Sermorelin Pen, reconstituted in 3ml of BAC Water.
Beginner Dosing Protocol
| DOSE | SCHEDULE | PEN DIAL NUMBER | WEEKLY TOTAL |
|---|---|---|---|
| 100 mcg | 5 nights per week | 6 | 500 mcg |
| 200 mcg | 5 nights per week | 12 | 1,000 mcg |
Duration and progression
3 months, beginning with 100 mcg for the first two weeks before increasing to 200 mcg.
Understanding the figures
Setting 6 delivers 0.06 ml containing 100 mcg. Setting 12 delivers 0.12 ml containing 200 mcg. Settings apply to each administration, not the weekly total.
Intermediate Dosing Protocol
| DOSE | SCHEDULE | PEN DIAL NUMBER | WEEKLY TOTAL |
|---|---|---|---|
| 200 mcg | 5 nights per week | 12 | 1,000 mcg |
| 300 mcg | 5 nights per week | 18 | 1,500 mcg |
Duration and progression
3–6 months, start on the lower end of the dose at 200 mcg and increase steadily across months 3-4 up to 300 mcg
Understanding the figures
Setting 12 delivers 0.12 ml containing 200 mcg. Setting 18 delivers 0.18 ml containing 300 mcg. Settings apply to each administration, not the weekly total.
Advanced Dosing Protocol
| DOSE | SCHEDULE | PEN DIAL NUMBER | WEEKLY TOTAL |
|---|---|---|---|
| 300 mcg | 5–7 nights per week | 18 | 1,500–2,100 mcg |
| 500 mcg | 5–7 nights per week | 30 | 2,500–3,500 mcg |
Duration and progression
4–6 months. start on the lower end of the dose at 300 mcg and increase steadily across months 3-4 up to 500 mcg
Understanding the figures
Setting 18 delivers 0.18 ml containing 300 mcg. Setting 30 delivers 0.30 ml containing 500 mcg. Weekly totals vary with the number of administrations.
Important Information